| Dr Dale Roberts Sackett, DDS | |
|
312 N 8th St W, Riverton, WY 82501-3315 | |
| (307) 856-2778 | |
| Not Available |
| Full Name | Dr Dale Roberts Sackett |
|---|---|
| Gender | Male |
| Speciality | Dentist - General Practice |
| Location | 312 N 8th St W, Riverton, Wyoming |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1215081690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1223G0001X | Dentist - General Practice | 703 (Wyoming) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Dale Roberts Sackett, DDS 312 N 8th St W, Riverton, WY 82501-3315 Ph: (307) 856-2778 | Dr Dale Roberts Sackett, DDS 312 N 8th St W, Riverton, WY 82501-3315 Ph: (307) 856-2778 |
News Archive
Based on its recent research on the surgical drapes, gowns and gloves market, Frost & Sullivan presents Ansell Healthcare Europe (Ansell Healthcare) with the "2010 European Surgical Gloves Product Quality Leadership Award" for its Encore® range of surgical gloves. The range consists of multiple products that are customized to support a wide range of surgical procedures including specialty surgery such as orthopaedics and microsurgery.
Obesity is a major public-health problem in the United States and around the world, with an estimated 650 million people suffering from the condition.
A decade of refinements in marrow and stem cell transplantation to treat blood cancers significantly reduced the risk of treatment-related complications and death, according to an institutional self-analysis of transplant-patient outcomes conducted at Fred Hutchinson Cancer Research Center.
Type 1 diabetes, or T1D, is an autoimmune disease in which the body's immune cells -; led by inflammatory macrophages -; attack and destroy the beta cells of the pancreas that produce insulin.
Idera Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing Toll-like receptor (TLR) and RNA therapeutics for patients with cancer and rare diseases, today announced that the company has commenced enrollment in a Phase 2 clinical trial of IMO-8400, an investigational TLR 7, 8 and 9 antagonist, in patients with dermatomyositis. Dermatomyositis is a rare and debilitating inflammatory muscle and skin disease associated with significant morbidity, decreased quality of life and an increased risk of premature death.
› Verified 4 days ago
Dr. James F. Mcfarlane, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 203 E Main St, Riverton, WY 82501 Phone: 307-857-2020 Fax: 307-857-2727 | |
Dr. Tyler A. Graham, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 325 W Main St Ste G, Riverton, WY 82501 Phone: 307-856-5210 | |
Harold Macon, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 1224 E Jackson Ave, Riverton, WY 82501 Phone: 307-856-3463 Fax: 307-856-9910 | |
Brock L Olson, DMD Dentist Medicare: Medicare Enrolled Practice Location: 621 N 8th St W, Riverton, WY 82501 Phone: 307-856-9725 Fax: 307-856-7075 | |
Dr. Guy Salisbury Menefee, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 325 W Main St Ste G, Riverton, WY 82501 Phone: 307-856-5210 | |
Dr. Terrin Melvin Porter, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 203 E Main St Ste 205, Riverton, WY 82501 Phone: 907-602-8678 Fax: 307-237-4424 |